China Geographic Atrophy Market: How Are Complement Inhibitors Creating the Treatment Market?
Complement inhibitor therapy for geographic atrophy — the C3 inhibitor pegcetacoplan (Syfovre) and C5 inhibitor avacincaptad pegol (Izervay) representing the first approved GA treatments and the foundation of the emerging GA pharmaceutical market — creates the commercial opportunity, with the China Geographic Atrophy Market reflecting complement inhibition as the foundational...
0 Comentários 0 Compartilhamentos 71 Visualizações 0 Anterior